Addus HomeCare’s (NASDAQ:ADUS) Q3 2026 earnings results: revenue in line with expectations
Addus HomeCare (ADUS) reported Q3 2026 revenue of $387.7M, up 7% YoY, meeting expectations. Adjusted EPS of $1.83 beat estimates by 2.1%. Operating margin improved to 10.3% from 9.1% YoY. The company expects revenue growth of 6.1% over the next 12 months, according to S&P.
How this was made

The 30-second read
Why it matters
The earnings beat provides a modest positive signal, but the immediate price reaction was flat, indicating limited short‑term trading urgency.
Market read
First‑report earnings with a small beat; modest relevance for traders focused on healthcare small caps.
What to watch
Liquidity from the revolving credit facility and pending AccentCare acquisition could become catalysts later.
Background
Addus HomeCare is a $2.3 B market‑cap home‑healthcare provider that posted Q3 2026 results with revenue up 7% YoY and EPS beat.
Ticker impact
Addus HomeCare reported Q3 2026 earnings beating revenue and EPS estimates, with revenue in line and EPS up 2.1% versus consensus.
potential modest upside as the beat could attract short‑term buyers
The beat is modest and the stock opened flat; investors may test the level before any sustained move.
Market effects
Adds a small positive data point for the home‑healthcare services sector, but no broader sector shift.
Limited to U.S. small‑cap healthcare investors.
Minimal global impact.
Counterpoint
Despite the beat, the flat price suggests the market may have already priced in growth, so a pull‑back is possible.
Key entities
- CompanyAddus HomeCare
NASDAQ‑listed home‑healthcare provider reporting Q3 2026 earnings.


